The Future of Biotech R&D in the UAE
Dr. Aaron Han, MD, PhD, Alliance Care Technologies Chief Medical Officer to speak at Advance Health Dubai Science Park 20th May
Alliance Care Technologies’ Chief Medical Officer and Chairman of the Board of Directors, Aaron Han, MD, PhD, will join a panel of experts to discuss the UAE’s role in driving innovation from within to improve healthcare locally, regionally, and globally.
The esteemed panel, moderated by Marwan Abdulaziz Janahi, Managing Director of Dubai Science Park, will be discussing innovation from the perspectives of pharma, investment, hospitals, academia, and SME.
Dr. Aaron will join expert panelists Dr. Nadine Tarcha, Medical Director, Gulf at Pfizer and Dr. Hemad Yasael, Dubai Genetics Center, Pathology and Genetics Department, Dubai Health Authority to share his knowledge and insights into the future R&D innovation in UAE Healthcare
The Advance Health Forum brings together healthcare stakeholders and key opinion leaders in the UAE. Healthcare is a central part of UAE’s strategic goals, with priorities including healthcare of the highest international standards, innovation in e-health and smart health, and world-leading medical tourism. This session will explore how the UAE is driving innovation from within to improve health care locally, regionally, and globally. innovation from within to improve healthcare locally, regionally, and globally.
About Aaron Han, MD, PhD:
Aaron Han, MD, PhD, is Chief Medical Officer for Alliance Care Technologies. He is a Consultant Pathologist with a special interest in hematology and coagulation disorders. An MD and PhD from Baylor College of Medicine, Dr Aaron is American Board Certified in Anatomic and Clinical Pathology and holds a special qualification in Hematology. He holds a joint faculty appointment at Mohammed bin Rashid University School of Medicine. Dr. Han is the Group Chair of Pathology for King’s College of London Middle East.
